Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: Results of a pilot study in 20 patients-Reference-Cited by-同舟云学术

Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: Results of a pilot study in 20 patients

Published:1991-07 Issue:7 Volume:2 Page:505-509
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Radford J.A.,Crowter D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/2/7/505/455491/2-7-505.pdf

Reference15 articles.

1. Intensive combination chemotherapy with vincristine, Adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma;Blackledge;Eur J Cancer,1980

2. VAPEC-B chemotherapy for diffuse histology NHL – results of a collaborative trial and the value of serum LDH in predicting relapse after CR in stages III/TV. Fourth International Conference on Malignant Lymphoma;Radford,1990

3. Chemotherapy of malignant lymphoma with adriamycin;Gottlieb;Cancer Res,1973

4. Management of patients with malignant lymphoma: A comparative study with cyclophosphamide and vinca alkaloids;Carbone;Cancer Res,1968

5. Evaluation of VP–16–213 in malignant lymphoma and melanoma;Cecil;Cancer Treat Rep,1978

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience;Annals of Oncology;2010-10

2. Survival in Young Patients (Less than 40 Years) with Follicular Lymphoma: A population Based Study by the Scotland and Newcastle Lymphoma Group;Leukemia & Lymphoma;2004-06

3. ChlVPP/EVA Hybrid Versus the Weekly VAPEC-B Regimen for Previously Untreated Hodgkin’s Disease;Journal of Clinical Oncology;2002-07-01

4. High-Dose Therapy and Autologous Stem-Cell Transplantation Versus Conventional-Dose Consolidation/Maintenance Therapy as Postremission Therapy for Adult Patients With Lymphoblastic Lymphoma: Results of a Randomized Trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group;Journal of Clinical Oncology;2001-06-01

5. CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma;Medical Oncology;2000-08